← USPTO Patent Grants

Techniques for modelling and optimizing dialysis toxin displacer compounds

Grant US12597482B2 Kind: B2 Apr 07, 2026

Assignee

Fresenius Medical Care Holdings, Inc.

Inventors

Xia Tao, Vaibhav Maheshwari, Peter Kotanko, Stephan Thijssen, Nadja Grobe

Abstract

Systems, methods, and/or apparatuses may be operative to perform a dialysis process that includes a displacer infusion process. In one embodiment, a method for determining a displacer compound may include constructing a plurality of target protein quantitative structure-activity relationship (QSAR) models, one for each of the plurality of binding sites, analyzing a set of candidate compounds using the plurality of QSAR models to determine a set of at least one potential compound with an affinity for binding to each of the plurality of binding sites, and selecting at least one displacer compound from the set of at least one potential compound. Other embodiments are described.

CPC Classifications

A61M 1/1613 A61M 1/1676 G16B 15/30 G16B 5/20 G16C 20/64 G16C 20/30 G16H 20/17 G16H 20/40 G16H 50/50

Filing Date

2023-03-30

Application No.

18128557

Claims

20